Stock code: 688363 Stock abbreviation: Bloomage Biotech Announcement No.: 2025-003

The time zone of Bloomage Biotechnology Co., Ltd.'s shareholder reduction plan

Announcement of the results of the expiration and reduction of shareholdings

The board of directors, all directors and relevant shareholders of the company guarantee that there are no false records, misleading statements or material omissions in the content of this announcement, and assume legal responsibility for the authenticity, accuracy and completeness of its content in accordance with the law.

Important Content Notes:

The basic situation of the shareholding of the major shareholder

Before the implementation of the shareholding reduction plan, China Life Chengda (Shanghai) Health Industry Equity Investment Center (Limited Partnership) (hereinafter referred to as "China Life Chengda") directly held 34,433,286 shares of Bloomage Biotechnology Co., Ltd. (hereinafter referred to as the "Company"), accounting for 7.15% of the total share capital of the Company. All of the above shares are:

The Company's pre-IPO shares have been listed for circulation since November 7, 2022.

The results of the implementation of the shareholding reduction plan

On October 9, 2024, the Company disclosed the "Shareholders of Bloomage Biotechnology Co., Ltd. Reduced Their Shareholdings

According to the plan announcement (Announcement No.: 2024-034), China Life Chengda plans to reduce its total holdings of the company's shares by centralized bidding and block trading according to market conditions not more than 12,041,955 shares, and the number of shares to be reduced will not exceed 2.50% of the total share capital of the company, of which the proportion of the reduction by centralized bidding will not exceed 1.00%, and the number of shares to be reduced will not exceed 4,816,782 shares; The proportion of holdings reduced by block trading is not exceeded

1.50%, the number of shares to be reduced will not exceed 7,225,173 shares, and the reduction period will be 3 after 15 trading days of the announcement

Within the month, i.e., October 31, 2024 to January 28, 2025.

As of January 28, 2025, the time period for this reduction has expired, and China Life Chengda is within the reduction period

A total of 5,496,782 shares of the Company were reduced, accounting for 1.14% of the total share capital of the Company, of which the centralized bidder was used

4,816,782 shares, accounting for 1.00% of the total share capital of the Company, and 680,000 shares by block trading,

It accounts for 0.14% of the company's total share capital, and the actual number of reductions accounts for 45.65% of the planned reductions.

1. The basic situation of the subject before the reduction

Name of shareholder Identity of shareholder Number of shares held (shares) Shareholding ratio Source of current shares

China Life achieved more than 5% non-first 34,433,286 7.15% Pre-IPO acquisition: 34,433,286

(Shanghai) Jian major shareholder shares

Kang Industrial Stocks

rights investment

Heart (finite combination

Gang)

There is no person acting in concert with the above-mentioned shareholding reduction entities.

Second, the results of the implementation of the shareholding reduction plan

(1) The major shareholder discloses the results of the implementation of the shareholding reduction plan due to the following matters:

The disclosed time range for reducing holdings expires

Number of holdings Reduction price area Total amount of reduction Completion of reduction Current holdings Current holdings Current holdings

Name of Shareholder (Shares) Shareholding Reduction Ratio Shareholding Reduction Period Shareholding Reduction Method Intermediate (RMB) Situation Number (Shares) Proportion

(RMB/Share)

China Life Chengda 5,496,782 1.14% 2024/10/31~ Centralized bidding 59.280- 341,152,301.72 Uncompleted: 28,936,504 6.01%

(Shanghai) 2024/11/12 Trading, large 68.100 6,545,173 shares

Health Industry Transactions

Equity investment

Center (Yes.)

Partnership Only)

Note: China Life Chengda reduced its holdings of 4,816,782 shares of the Company by centralized auction trading from October 31, 2024 to November 12, 2024, accounting for 1.00% of the total share capital of the Company; National life into the reach

During the period from November 7, 2024 to November 12, 2024, 680,000 shares of the Company were reduced by way of block trading, representing 0.14% of the total share capital of the Company.

(2) Whether the actual shareholding reduction is consistent with the previously disclosed shareholding reduction plan and commitment √ yes or □no

(3) Whether the shareholding reduction has not been implemented □ has not been implemented √ has been implemented upon the expiration of the time period for the reduction

(4) Whether the actual reduction has not reached the minimum number (proportion) of the shareholding reduction plan, □ has not been reached, √ has been reached

(5) Whether to terminate the shareholding reduction plan ahead of schedule □Yes √ No

The announcement is hereby made.

Board of Directors of Bloomage Biotechnology Co., Ltd

January 28, 2025